Improved survival for patients diagnosed with chronic lymphocytic leukemia in the era of chemo-immunotherapy: a Danish population-based study of 10455 patients

The treatment of chronic lymphocytic leukemia (CLL) is in rapid transition, and during recent decades both combination chemotherapy and immunotherapy have been introduced. To evaluate the effects of this development, we identified all CLL patients registered in the nation-wide Danish Cancer Register...

Descripción completa

Detalles Bibliográficos
Autores principales: da Cunha-Bang, C, Simonsen, J, Rostgaard, K, Geisler, C, Hjalgrim, H, Niemann, C U
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5148052/
https://www.ncbi.nlm.nih.gov/pubmed/27834937
http://dx.doi.org/10.1038/bcj.2016.105

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5148052/
https://www.ncbi.nlm.nih.gov/pubmed/27834937
http://dx.doi.org/10.1038/bcj.2016.105

Ejemplares similares